This investor-partnership competition supports late-stage development and adoption of engineered biological products and services. Eligible themes include health, food and agriculture, chemicals and materials, low-carbon fuels, waste and environment, and enabling technologies. Projects must offer a credible route to market and company growth. Grant requests range from £250,000 to £2 million for 24-month projects, with funding rates depending on business size. A designated investor must lead aligned private financing worth at least twice the grant. Applications close on 2 December 2026 at 11:00
In Biotechnology and Synthetic Biology
This business-led collaborative research and development competition will fund new engineering-biology products, processes and services and de-risk technologies with strong market potential. Projects may address health, agriculture and food, chemicals and materials, low-carbon fuels, waste and environment, or cross-cutting technology and service development. The central innovation must purposefully engineer biological systems and may involve biosensors, biomanufacturing, synthetic-biology platforms, gene editing, AI or computational biology. Projects must have total eligible costs of £750,000